(Press-News.org) (Toronto, February 17, 2026) JMIR Publications invites submissions to a new theme issue titled “Bridging Data, AI, and Innovation to Transform Health” in its open access journal JMIR Bioinformatics and Biotechnology. The premier, peer-reviewed journal is indexed in PubMed- and Scopus and is the official journal of the MidSouth Computational Biology and Bioinformatics Society.
This theme issue explores the convergence of computational biology, artificial intelligence (AI), and health care innovation. As AI continues to revolutionize diagnostics, treatment, and drug discovery, the journal invites researchers, clinicians, and technologists to share original research and insights that pave the way for a future of precision medicine and enhanced patient care.
This open call for papers will also accept submissions from the MCBIOS 2026 Conference (March 27-29, 2026, Moffitt Cancer Center, Tampa, FL). Conference participants are highly encouraged to submit their expanded research and findings to this theme issue.
The scope of this call for papers includes, but is not limited to, the following topics:
AI in medicine: innovative applications of machine learning and deep learning in diagnostics, treatment modeling, and personalized medicine.
Computational genomics and precision oncology: breakthroughs in genomic data analysis, and epigenetic regulation to transform cancer research and treatment.
Radiogenomics and imaging: AI applications in radiology, image analysis for tumor detection, and integration of imaging with molecular data.
Drug discovery: computational modeling and AI-driven pipelines for accelerating drug development and repurposing.
Large-language models (LLMs): innovative applications of LLMs in genomics, bioinformatics, and related data, including analysis of clinical text, tabular data, and web-based bioinformatics tools.
Digital twins in healthcare: computational patient modeling, virtual cohorts, predictive simulation, and AI-enabled genomic digital twins for genomics-driven personalized medicine and health care optimization.
To learn more please visit the webpage.
About The MidSouth Computational Biology and Bioinformatics Society (MCBIOS)
The MidSouth Computational Biology and Bioinformatics Society (MCBIOS) is a key scientific and professional organization dedicated to fostering the professional development of its members and promoting the advancement of computational biology and bioinformatics through annual conferences, education, networking, and the dissemination of research.
To learn more about MCBIOS, please visit mcbios.com
About JMIR Publications
JMIR Publications is a leading open access publisher of digital health research and a champion of open science. With a focus on author advocacy and research amplification, JMIR Publications partners with researchers to advance their careers and maximize the impact of their work. As a technology organization with publishing at its core, we provide innovative tools and resources that go beyond traditional publishing, supporting researchers at every step of the dissemination process. Our portfolio features a range of peer-reviewed journals, including the renowned Journal of Medical Internet Research.
To learn more about JMIR Publications, please visit jmirpublications.com or connect with us via Twitter, LinkedIn, YouTube, Facebook, and Instagram.
Head office: 130 Queens Quay East, Unit 1100, Toronto, ON, M5A 0P6 Canada
Media Contact:
Dennis O’Brien, Vice President, Communications & Partnerships
JMIR Publications
communications@jmir.org
The content of this communication is licensed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, published by JMIR Publications, is properly cited.
END
JMIR Publications’ JMIR Bioinformatics and Biotechnology invites submissions on Bridging Data, AI, and Innovation to Transform Health
2026-02-17
ELSE PRESS RELEASES FROM THIS DATE:
Honey bees navigate more precisely than previously thought
2026-02-17
A team from the University of Freiburg led by neurobiologist and behavioural biologist Prof. Dr. Andrew Straw studied the flight behaviour of honey bees. Using a drone, the researchers tracked honey bees as they flew between their hive and a food source about 120 metres away in an agricultural environment. In order to observe the bees on their respective routes, the scientists used the ‘Fast Lock-On (FLO) Tracking’ method developed by Straw's working group. This involves attaching a small, highly reflective marker to the insect. On the drone, a computer uses image analysis of reflected light to reliably locate the bee within a few milliseconds and keep track ...
Air pollution may directly contribute to Alzheimer’s disease
2026-02-17
People with greater exposure to air pollution face a higher risk of developing Alzheimer’s disease, according to a new study by Yanling Deng of Emory University, U.S.A., and colleagues, published February 17th in the open-access journal PLOS Medicine.
Alzheimer’s disease is the most common form of dementia, affecting about 57 million people worldwide. Exposure to air pollution is a known risk factor for Alzheimer’s disease, and for several common chronic health conditions, such as hypertension, stroke and depression. ...
Study finds early imaging after pediatric UTIs may do more harm than good
2026-02-17
CHICAGO — Feb. 17, 2026 — A new study from the Advocate Aurora Research Institute — which is part of Advocate Health — published Tuesday in Hospital Pediatrics provides guidance for families and physicians caring for infants and young children hospitalized with a febrile urinary tract infection (UTI), one of the most common infections in early childhood.
The findings provide insight that could reduce the chances of unnecessary tests for children and added stress for families and could also help ...
UC San Diego Health joins national research for maternal-fetal care
2026-02-17
The University of California San Diego School of Medicine and UC San Diego Health, in collaboration with UC San Francisco and UCSF Health, have joined the Maternal-Fetal Medicine Units (MFMU) Network at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), expanding clinical trial access and advancing obstetric care for patients in Southern California.
Established in 1986, the MFMU Network conducts research that focuses on pregnancy and newborn health.
“Joining the ...
New biomarker predicts chemotherapy response in triple-negative breast cancer
2026-02-17
Patients with triple-negative breast cancer have different treatment responses
Computational tools that predict treatment response historically overlook gene expression changes relative to the tumor microenvironment
New computational approach outperformed current methods for predicting chemotherapy response in patients with triple-negative breast cancer
Biomarker also directs some patients to alternative therapy and highlights population-specific differences between Asian and European tumors
Researchers at The University of Texas MD Anderson Cancer Center have developed a new computational approach designed to better account for changes in gene expression within tumors ...
Treatment algorithms featured in Brain Trauma Foundation’s update of guidelines for care of patients with penetrating traumatic brain injury
2026-02-17
February 17, 2026 — The Brain Trauma Foundation has updated the 2001 evidence-based guidelines for the care of patients with penetrating traumatic brain injury (pTBI). A working group of more than 30 expert panelists developed over 30 new evidence-based recommendations. To provide a bridge between these recommendations and complexities of care at the bedside, panelists also used a rigorous Delphi process to develop consensus statements as well as treatment algorithms for the guidelines. The guidelines and algorithms are published together as a supplement to the March 2026 issue of Neurosurgery, the ...
Over 40% of musicians experience tinnitus; hearing loss and hyperacusis also significantly elevated
2026-02-17
A new systematic review and meta-analysis published in Otolaryngology–Head and Neck Surgery, the official journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF), reveals that musicians face substantially higher rates of tinnitus, hearing loss, and hyperacusis compared to non-musicians. The study, which pooled data from 67 studies encompassing more than 28,000 musicians across 21 countries.
The research found that 42.6% of musicians reported tinnitus (ringing in the ears), compared ...
Artificial intelligence predicts colorectal cancer risk in ulcerative colitis patients
2026-02-17
People with ulcerative colitis (UC), a chronic inflammatory bowel disease, are up to four times more likely to develop colorectal cancer than the general population. Low‑grade dysplasia (LGD) — abnormal or precancerous lesions — can be an early warning sign, but only a fraction of UC‑LGD cases progress to cancer. This makes it challenging for clinicians and patients to make informed care decisions, ranging from continued surveillance to preventative surgery.
Now, a new study led by researchers at University ...
Mayo Clinic installs first magnetic nanoparticle hyperthermia system for cancer research in the US
2026-02-17
ROCHESTER, Minn. — Mayo Clinic collaborated with New Phase Ltd. to install the first magnetic nanoparticle-mediated hyperthermia machine for cancer research in the U.S. Hyperthermia is a procedure that uses heat to damage and kill cancer cells. The investigational machine will support research evaluating the safety, feasibility and potential effectiveness of this approach in cancer treatment.
"We have known for more than a century that temperature is the Achilles' heel of cancer, but conventional hyperthermia has limitations and is not widely available," says Scott Lester, M.D., a radiation ...
Calibr-Skaggs and Kainomyx launch collaboration to pioneer novel malaria treatments
2026-02-17
La Jolla, CA and Palo Alto, CA—The Calibr-Skaggs Institute for Innovative Medicines at Scripps Research and Kainomyx, Inc., today announced a new research collaboration to accelerate the discovery and development of next-generation antimalarial drugs. This partnership, supported by the Gates Foundation, brings together Calibr-Skaggs’ world-class drug discovery platform and Kainomyx’s innovative focus on cytoskeletal targets in the Plasmodium species of the parasite that are responsible for the deadliest form of malaria.
Meeting the Unmet Need in Malaria
Malaria remains one of the world’s most devastating infectious diseases, with over 280 million ...